用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
Alfa Wassermann S.p.a.(149)
ALFA WASSERMANN SPA(31)
SALIX PHARMACEUTICALS LTD [US](31)
Salix Pharmaceuticals, Ltd.(25)
ALFA WASSERMANN SPA [IT](24)
Alfa Wassermann, S.p.a.(21)
CIPLA LTD [IN](12)
Cipla Limited(11)
LUPIN LTD [IN](11)
CIPLA LTD(10)
专利信息
Translation Company
查询条件
展开筛选条件
[药品] 包含 'Rifaximin'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
3
4
5
6
下页
尾页
共
529
条记录, 当前第1/53页。
公开号
公开日
申请号
申请日
1.
EP2710015A1
2014/3/26
EP20120731691
2012/5/18
专利标题
:POLYMORPH OF RIFAXIMIN AND PROCESS FOR THE PREPARATION THEREOF
专利权人
:
CLAROCHEM IRELAND LTD [IE]
;
2.
EP2710014A1
2014/3/26
EP20120721559
2012/5/21
专利标题
:NEW PROCESS FOR THE SYNTHESIS OF RIFAXIMIN AND A NEW PSEUDO-CRYSTALLINE FORM OF RIFAXIMIN OBTAINED THEREBY
专利权人
:
FRIULCHEM SPA [IT]
;
3.
WO2014043433A1
2014/3/20
WO2013US59590
2013/9/13
专利标题
:METHODS OF IMPROVING LONG-TERM SURVIVAL AND REDUCING HOSPITALIZATION READMISSION RATES FOR SUBJECTS SUFFERING FROM HEPATIC ENCEPHALOPATHY
专利权人
:
SALIX PHARMACEUTICALS LTD [US]
;
NEFF GUY [US]
;
Methods of increasing the long-term survival odds for a subject suffering from hepatic encephalopathy are provided, wherein the methods include administering a composition comprising rifaximin to the subject. Methods of reducing the frequency of hospitalization visits by a subject suffering from HE are also provided, wherein the methods include administering a composition comprising rifaximin to the subject.
4.
WO2014043432A1
2014/3/20
WO2013US59589
2013/9/13
专利标题
:METHODS OF ADMINISTERING RIFAXIMIN FOR WEIGHT LOSS AND TREATMENT OF OBESITY
专利权人
:
SALIX PHARMACEUTICALS INC [US]
;
RANDALL CHARLES W [US]
;
Methods of reducing weight in a subject are provided, wherein the methods comprise administering a composition comprising an effective amount of rifaximin to a subject in need of treatment for weight loss. In some embodiments, the subject is considered obese (BMI > 30).
5.
WO2014043320A1
2014/3/20
WO2013US59415
2013/9/12
专利标题
:METHODS OF ADMINISTERING RIFAXIMIN WITHOUT PRODUCING ANTIBIOTIC RESISTANCE
专利权人
:
SALIX PHARMACEUTICALS INC [US]
;
Methods of administering a composition comprising rifaximin to a subject in need thereof are provided, wherein the methods do not increase development of rifampicin resistance to a Staphylococcus spp. Methods of reducing the development of rifampicin resistance to a Staphylococcus spp. are also provided, comprising administering a composition comprising rifaximin to a subject in need thereof.
6.
US2014079783A1
2014/3/20
US201313935331
2013/7/3
专利标题
:Pharmaceutical Compositions Comprising Rifaximin and Amino acids, Preparation Methods and Use Thereof
专利权人
:
ALFA WASSERMANN SPA [IT]
;
The present invention relates to rifaximin compositions comprising amino acids, characterized in that they increase rifaximin solubility in aqueous solutions and are useful in the treatment of disease wherein amino acids and rifaximin are efficacious. The present invention also relates to pharmaceutical compositions comprising rifaximin or one of the pharmaceutically acceptable salts thereof and one or more amino acid(s), wherein the molar ratio between the amino acid(s) and rifaximin is from 1:...
7.
US20140079783A1
2014/3/20
专利标题
:Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof
专利权人
:
ALFA WASSERMANN SPA
;
The present invention relates to rifaximin compositions comprising amino acids characterized in that they increase rifaximin solubility in aqueous solutions and are useful in the treatment of disease wherein amino acids and rifaximin are efficacious. The present invention also relates to pharmaceutical compositions comprising rifaximin or one of the pharmaceutically acceptable salts thereof and one or more amino acid(s) wherein the molar ratio between the amino acid(s) and rifaximin is from 1:1 ...
8.
EP2705042A1
2014/3/12
EP20120721936
2012/5/2
专利标题
:RIFAXIMIN DIMETHYLFORMAMIDE SOLVATE
专利权人
:
RANBAXY LAB LTD [IN]
;
9.
CN103619852A
2014/3/5
专利标题
:Polymorphic form of rifaximin and preparation method thereof
专利权人
:
10.
KR20140015140A
2014/2/6
KR20127012479
2010/10/27
专利标题
:SOLID DISPERSION OF RIFAXIMIN
专利权人
:
LUPIN LTD [IN]
;
首页
1
2
3
4
5
6
下页
尾页
共
529
条记录, 当前第1/53页。
当前查询条件: [药品] 包含 'Rifaximin'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文